Potent dual cdk1/cdk2 inhibitor (IC50
values are 20 and 50 nM, respectively). Also displays low micromolar activity at PKCα
. Displays reversible G1
/S cell cycle arrest in U2-OS cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Novel and efficient access to phenylamino-pyrimidine type protein kinase C inhibitors utilizing a Negishi cross-coupling strategy.
Stanetty et al.
Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.
Sielecki et al.